Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors

被引:151
作者
Miyazaki, Y
Matsunaga, S
Tang, J
Maeda, Y
Nakano, M
Philippe, RJ
Shibahara, M
Liu, W
Sato, H
Wang, LP
Nolte, RT
机构
[1] GlaxoSmithKline KK, Tsukuba Res Labs, Tsukuba, Ibaraki 3004247, Japan
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1016/j.bmcl.2005.03.034
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of furo[2,3-d]pyrimidines has been discovered as potent dual inhibitors of Tie-2 and VEGFR2 receptor tyrosine kinases (TK) and a diarylurea moiety at 5-position shows remarkably enhanced activity against both enzymes. One of the most active compounds, 4-amino-3-(4-((2-fluoro-5-(trifluoromethyl)phenyl)amino-carbonylamino)phenyl)-2-(4-methoxyphenyl)furo[2,3-d]pyrimidine (7k) is < 3 nM on both TK receptors and the activity is rationalized based on the X-ray crystal structure. © 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2203 / 2207
页数:5
相关论文
共 18 条
  • [1] ADAMS JJ, 2003, Patent No. 03022852
  • [2] BILODEAU MT, 2002, EXPERT OPIN INV DRUG, V99, P11393
  • [3] Boyer Stephen J., 2002, Current Topics in Medicinal Chemistry, V2, P973, DOI 10.2174/1568026023393273
  • [4] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [5] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [6] Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
    Davis, S
    Aldrich, TH
    Jones, PF
    Acheson, A
    Compton, DL
    Jain, V
    Ryan, TE
    Bruno, J
    Radziejewski, C
    Maisonpierre, PC
    Yancopoulos, GD
    [J]. CELL, 1996, 87 (07) : 1161 - 1169
  • [7] The biology of vascular endothelial growth factor
    Ferrara, N
    DavisSmyth, T
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
  • [8] ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE
    FOLKMAN, J
    [J]. NATURE MEDICINE, 1995, 1 (01) : 27 - 31
  • [9] Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    Hanahan, D
    Folkman, J
    [J]. CELL, 1996, 86 (03) : 353 - 364
  • [10] Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
    Holash, J
    Maisonpierre, PC
    Compton, D
    Boland, P
    Alexander, CR
    Zagzag, D
    Yancopoulos, GD
    Wiegand, SJ
    [J]. SCIENCE, 1999, 284 (5422) : 1994 - 1998